Kraig Biocraft Laboratories, Inc Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Kraig Biocraft Laboratories, Inc quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Kraig Biocraft Laboratories, Inc Debt-to-equity for the quarter ending September 30, 2024 was -139 %, a 28.7% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -139 +55.9 +28.7% Sep 30, 2024
Q2 2024 -150 +61.3 +29.1% Jun 30, 2024
Q1 2024 -163 +64 +28.2% Mar 31, 2024
Q4 2023 -177 +51.8 +22.6% Dec 31, 2023
Q3 2023 -195 +11.5 +5.56% Sep 30, 2023
Q2 2023 -211 -24.9 -13.4% Jun 30, 2023
Q1 2023 -227 -52.7 -30.3% Mar 31, 2023
Q4 2022 -229 -78 -51.7% Dec 31, 2022
Q3 2022 -206 -65.2 -46.2% Sep 30, 2022
Q2 2022 -186 -57.3 -44.6% Jun 30, 2022
Q1 2022 -174 -60 -52.6% Mar 31, 2022
Q4 2021 -151 -39.3 -35.1% Dec 31, 2021
Q3 2021 -141 -31 -28.1% Sep 30, 2021
Q2 2021 -129 -15.8 -14% Jun 30, 2021
Q1 2021 -114 +3.64 +3.09% Mar 31, 2021
Q4 2020 -112 +11.1 +9% Dec 31, 2020
Q3 2020 -110 +9.84 +8.2% Sep 30, 2020
Q2 2020 -113 Jun 30, 2020
Q1 2020 -118 Mar 31, 2020
Q4 2019 -123 Dec 31, 2019
Q3 2019 -120 Sep 30, 2019
Q2 2017 -114 Jun 30, 2017
Q1 2017 -113 Mar 31, 2017
Q4 2016 -113 Dec 31, 2016
Q3 2016 -113 Sep 30, 2016
Q4 2013 -116 +7.03 +5.74% Dec 31, 2013
Q3 2013 -111 +17.1 +13.3% Sep 30, 2013
Q2 2013 -111 +16.5 +12.9% Jun 30, 2013
Q1 2013 -117 +5.42 +4.43% Mar 31, 2013
Q4 2012 -123 Dec 31, 2012
Q3 2012 -128 Sep 30, 2012
Q2 2012 -128 Jun 30, 2012
Q1 2012 -122 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.